Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia (Q33388109)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia |
scientific article |
Statements
1 reference
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia (English)
1 reference
Michele Baccarani
1 reference
Miriam Isola
1 reference
Renato Fanin
1 reference
Francesco Zaja
1 reference
Patrizio Mazza
1 reference
Monica Bocchia
1 reference
Luigi Gugliotta
1 reference
Alfonso Zaccaria
1 reference
Nicola Vianelli
1 reference
Marzia Defina
1 reference
Alessia Tieghi
1 reference
Selenia Campagna
1 reference
Felicetto Ferrara
1 reference
Emilio Usala
1 reference
Silvia Cantoni
1 reference
Giuseppe Visani
1 reference
Antonella Fornaro
1 reference
Francesco Casulli
1 reference
Marta Lisa Battista
1 reference
Franca Soldano
1 reference
Enrica Gamba
1 reference
3 February 2010
1 reference
1 reference
115
1 reference
14
1 reference
2755-2762
1 reference
Identifiers
1 reference
1 reference